This increasing reliance on bioreactors for pharmaceutical applications significantly contributes to market growth. The growing prevalence of chronic diseases and the rise of biologics have fueled ...

Pharmaceutical-grade industrial bioreactors are associated with numerous challenges due to the inherent complexity of biological systems housed within these devices, sterility requirements ...

Bora Biologics, a subsidiary of Tanvex Biopharma born out of a spinoff from Bora Pharmaceuticals, is expanding CDMO operations at its San Diego facility. The new project will add 8,075 square feet of ...

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The installation of the new vial, syringe, and cartridge line is expected to take place throughout the coming year.

To address the challenges in biologics manufacturing, pharmaceutical companies are ... all processes in a manufacturing plant. Automated bioreactors and purification systems ensure precise control ...

The expanded facility will feature two 2000L Cytiva XDR bioreactors and seed train, providing Bora Biologics’ clients with robust and scalable biologics manufacturing solutions. The upstream hall’s ...

Bioreactors are majorly used in the pharmaceutical and biotechnology industry for the production of vaccines, antibodies, or biological products. In addition, they are used in industrial processes for ...

The main customers of traditional bioreactors are research labs and the pharmaceutical industry ... growing cells without any knowledge of the biological details involved,” he says.

Biological reactions are very sensitive to changes in environmental factors. For this reason, bioreactors must ... already used in industry to produce pharmaceuticals, biochemicals, food ...